
Inogen INGN
$ 6.47
1.09%
Quarterly report 2026-Q1
added 05-08-2026
Inogen Interest Expense 2011-2026 | INGN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.44 M | 850 K | 468 K | -862 K | -710 K | 5.84 M | -229 K | -696 K | 1.3 M | 6 K | 22 K | 449 K | 562 K | 493 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.84 M | -862 K | 710 K |
Quarterly Interest Expense Inogen
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42 K | 606 K | 701 K | 356 K | - | 687 K | 134 K | 143 K | - | -398 K | 337 K | 237 K | - | -12 K | -722 K | -433 K | - | -466 K | 304 K | -310 K | - | -54 K | 5.7 M | -60 K | - | -503 K | 145 K | -120 K | - | 8 K | -1.05 M | 444 K | - | 264 K | 523 K | 207 K | - | 1 K | 2 K | 3 K | - | 5 K | 6 K | 7 K | - | 104 K | 203 K | 133 K | - | 113 K | 95 K | 104 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.7 M | -1.05 M | 185 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.37 | 1.63 % | $ 164 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.75 | 2.71 % | $ 333 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.13 | -1.75 % | $ 1.22 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.98 | -1.81 % | $ 71.5 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.31 | 0.99 % | $ 50.9 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.52 | -2.26 % | $ 61.8 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 18.04 | -1.8 % | $ 423 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.0 | -0.18 % | $ 394 M | ||
|
Myomo
MYO
|
-668 K | $ 1.05 | 0.48 % | $ 43.9 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 74.78 | 1.29 % | $ 4.08 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 9.84 | -8.51 % | $ 390 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.65 | 0.83 % | $ 539 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.91 | 1.18 % | $ 209 M | ||
|
Electromed
ELMD
|
455 K | $ 36.86 | -3.56 % | $ 312 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 4.67 | 4.36 % | $ 1.15 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.39 | - | $ 6.63 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 85.03 | 0.26 % | $ 11.5 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 155.01 | 0.09 % | $ 10.9 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 35.94 | -3.48 % | $ 1.12 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 42.62 | -2.78 % | $ 1.25 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 89.25 | -0.03 % | $ 3.1 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 86.88 | 1.28 % | $ 50.8 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 69.33 | 0.57 % | $ 2.36 B |